Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1334-1339

  Miller, Karen K ^a   Lawson, E A ^a   Mathur, V ^a   Wexler, T L ^a   Meenaghan, E ^a   Misra, M ^a   Herzog, D B ^a   Klibanski, A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AMENORRHEA; ANOREXIA NERVOSA; ARTICLE; BODY COMPOSITION; BONE DENSITY; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; HYPOTHALAMUS DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; WEIGHT;

EID: 34147150332     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2501     Document Type: Article

References (51)

1. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A 2005 Medical findings in outpatients with anorexia nervosa. Arch Intern Med 165: 561-566
2. Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A 1999 Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 84:2049-2055
3. Biller BM, Federoff HJ, Koenig JI, Klibanski A 1990 Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 70:311-317
4. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A 1989 Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 68:548-554
5. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A 1996 Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81:3864-3870
6. Estour B, Pugeat M, Lang F, Dechaud H, Pellet J, Rousset H 1986 Sex hormone binding globulin in women with anorexia nervosa. Clin Endocrinol (Oxf) 24:571-576
7. Sirinathsinghji DJ, Mills IH 1985 Concentration patterns of plasma dehydroepiandrosterone, -5-androstenediol and their sulphates, testosterone and cortisol in normal healthy women and in women with anorexia nervosa. Acta Endocrinol (Copenh) 108:255-260
8. Fisher EC, Nelson ME, Frontera WR, Turksoy RN, Evans WJ 1986 Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. J Clin Endocrinol Metab 62:1232-1236
9. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A 1999 The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 84:4489-4496
10. Skalba P, Zieba M, Olejek A 2001 [Testosterone and SHBG levels in blood serum in women with anorexia nervosa]. Wiad Lek 54:532-536 (Polish)
11. Devesa J, Perez-Fernandez R, Bokser L, Gaudiero GJ, Lima L, Casanueva FF 1988 Adrenal androgen secretion and dopaminergic activity in anorexia nervosa. Horm Metab Res 20:57-60
12. Brambilla F, Bellodi L, Arancio C, Limonta D, Ferrari E, Solerte B 2001 Neurotransmitter and hormonal background of hostility in anorexia nervosa. Neuropsychobiology 43:225-232
13. Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS 2002 Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 87:4935-4941
14. Zumoff B, Walsh BT, Katz JL, Levin J, Rosenfeld RS, Kream J, Weiner H 1983 Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab 56:668-672
15. Monteleone P, Luisi M, Colurcio B, Casarosa E, Ioime R, Genazzani AR, Maj M 2001 Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosom Med 63:62-68
16. Tomova A, Kumanov P, Kirilov G 1995 Factors related to sex hormone binding globulin concentrations in women with anorexia nervosa. Horm Metab Res 27:508-510
17. van Binsbergen CJ, Coelingh Bennink HJ, Odink J, Haspels AA, Koppeschaar HP 1990 A comparative and longitudinal study on endocrine changes related to ovarian function in patients with anorexia nervosa. J Clin Endocrinol Metab 71:705-711
18. Winterer J, Gwirtsman HE, George DT, Kaye WH, Loriaux DL, Cutler Jr GB 1985 Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery. J Clin Endocrinol Metab 61:693-697
19. Tutten A, Laan E, Panhuysen G, Everaerd W, de Haan E, Koppeschaar H, Vroon P 1996 Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychosom Med 58:234-241
20. Genazzani AD, Bersi C, Luisi S, Fruzzetti F, Malavasi B, Luisi M, Petraglia F, Genazzani AR 2001 Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. J Steroid Biochem Mol Biol 78: 247-252
21. Rickenlund A, Carlstrom K, Ekblom B, Brismar TB, von Schoultz B, Hirschberg AL 2003 Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance. Fertil Steril 79:947-955
22. Rickenlund A, Thoren M, Carlstrom K, von Schoultz B, Hirschberg AL 2004 Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab 89:702-707
23. de Rosa G, Corsello SM, de Rosa E, Della Casa S, Ruffilli MP, Grasso P, Pasargiklian E 1983 Endocrine study of anorexia nervosa. Exp Clin Endocrinol 82:160-172
24. Robinson E, Bachrach LK, Katzman DK 2000 Use of hormone replacement therapy to reduce the risk of osteopenia in adolescent girls with anorexia nervosa. J Adolesc Health 26:343-348
25. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC 1995 The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80:898-904
26. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A 2002 Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87:2883-2891
27. Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R 1996 Changes in androgens during treatment with four low-dose contraceptives. Contraception 53:171-176
28. Coenen CM, Thomas CM, Borm GF, Rolland R 1995 Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives. Int J Fertil Menopausal Stud 40(Suppl 2):92-97
29. White T, Jain JK, Stanczyk FZ 2005 Effect of oral versus transdermal steroidal contraceptives on androgenic markers. Am J Obstet Gynecol 192:2055-2059
30. Osmanagaoglu MA, Okumus B, Osmanagaoglu T, Bozkaya H 2004 The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. J Womens Health (Larchmt) 13: 993-999
31. Carlstrom K, Karlsson R, Von Schoultz B 2002 Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Invest 62:361-368
32. Murphy A, Cropp CS, Smith BS, Burkman RT, Zacur HA 1990 Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women. Fertil Steril 53:35-39
33. Fern M, Rose DP, Fern EB 1978 Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol 51:541-544
34. Wiegratz I, Jung-Hoffmann C, Kuhl H 1995 Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception 51:341-346
35. Moutos D, Smith S, Zacur H 1995 The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Contraception 52:105-109
36. Miller KK, Parulekar MS, Schoenfeld E, Anderson E, Hubbard J, Klibanski A, Grinspoon SK 1998 Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 83:2309-2312
37. American Psychiatric Association 2000 Diagnostic and statistical manual of mental disorder. 4th ed. (text revision). Arlington, VA: American Psychiatric Publishing, Inc.
38. Metropolitan Life Insurance Co 1983 Metropolitan height and weight tables. Stat Bull 64:2-9
39. Miller KK, Grinspoon S, Gleysteen S, Grieco KA, Ciampa J, Breu J, Herzog DB, Klibanski A 2004 Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab 89:4434-4438
40. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618-16123
41. Mazess RB, Barden HS, Bisek JP, Hanson J 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106-1112
42. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A 2004 Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525-533
43. Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A 2006 Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 91:1683-1690
44. Davis SR, McCloud P, Strauss BJ, Burger H 1995 Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21:227-236
45. Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Yang HM, Nolan J 1999 A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 44:1012-1020
46. Miller BE, De Souza MJ, Slade K, Luciano AA 2000 Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density. Menopause 7:318-326
47. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ 1995 Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 85:529-537
48. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC 1996 Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 97:14-21
49. Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, Phillips DL, Rogers TN, Clark RV 1989 Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 69: 533-539
50. Soyka LA, Misra M, Frenchman A, Miller KK, Grinspoon S, Schoenfeld DA, Klibanski A 2002 Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87:4177-4185
51. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS 2004 Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 89:534-543